ArticleClinical case reports2023

Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test.

Shun Ishido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.